Contrast Enhanced MRI in the Diagnosis of HCC.

Eric Niendorf, Benjamin Spilseth, Xiao Wang, Andrew Taylor

Research output: Contribution to journalArticle

Abstract

Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is performed with ultrasound. Confirmation of HCC can then be obtained by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), due to the relatively high specificity of both techniques. This article will focus on reviewing MRI techniques for imaging HCC, felt by many to be the exam of choice for HCC diagnosis. MRI relies heavily upon the use of gadolinium-based contrast agents and while primarily extracellular gadolinium-based contrast agents are used, there is an emerging role of hepatobiliary contrast agents in HCC imaging. The use of other non-contrast enhanced MRI techniques for assessing HCC will also be discussed and these MRI strategies will be reviewed in the context of the pathophysiology of HCC to help understand the MR imaging appearance of HCC.
Original languageEnglish (US)
Pages (from-to)383-398
Number of pages16
JournalDiagnostics (Basel, Switzerland)
Volume5
Issue number3
DOIs
StatePublished - 2015

Fingerprint

Hepatocellular Carcinoma
Magnetic Resonance Imaging
Contrast Media
Gadolinium
Tomography

Cite this

Contrast Enhanced MRI in the Diagnosis of HCC. / Niendorf, Eric; Spilseth, Benjamin; Wang, Xiao; Taylor, Andrew.

In: Diagnostics (Basel, Switzerland), Vol. 5, No. 3, 2015, p. 383-398.

Research output: Contribution to journalArticle

@article{21587cc17828455480b0646b8c3711e5,
title = "Contrast Enhanced MRI in the Diagnosis of HCC.",
abstract = "Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is performed with ultrasound. Confirmation of HCC can then be obtained by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), due to the relatively high specificity of both techniques. This article will focus on reviewing MRI techniques for imaging HCC, felt by many to be the exam of choice for HCC diagnosis. MRI relies heavily upon the use of gadolinium-based contrast agents and while primarily extracellular gadolinium-based contrast agents are used, there is an emerging role of hepatobiliary contrast agents in HCC imaging. The use of other non-contrast enhanced MRI techniques for assessing HCC will also be discussed and these MRI strategies will be reviewed in the context of the pathophysiology of HCC to help understand the MR imaging appearance of HCC.",
author = "Eric Niendorf and Benjamin Spilseth and Xiao Wang and Andrew Taylor",
year = "2015",
doi = "10.3390/diagnostics5030383",
language = "English (US)",
volume = "5",
pages = "383--398",
journal = "Diagnostics",
issn = "2075-4418",
publisher = "MDPI AG",
number = "3",

}

TY - JOUR

T1 - Contrast Enhanced MRI in the Diagnosis of HCC.

AU - Niendorf, Eric

AU - Spilseth, Benjamin

AU - Wang, Xiao

AU - Taylor, Andrew

PY - 2015

Y1 - 2015

N2 - Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is performed with ultrasound. Confirmation of HCC can then be obtained by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), due to the relatively high specificity of both techniques. This article will focus on reviewing MRI techniques for imaging HCC, felt by many to be the exam of choice for HCC diagnosis. MRI relies heavily upon the use of gadolinium-based contrast agents and while primarily extracellular gadolinium-based contrast agents are used, there is an emerging role of hepatobiliary contrast agents in HCC imaging. The use of other non-contrast enhanced MRI techniques for assessing HCC will also be discussed and these MRI strategies will be reviewed in the context of the pathophysiology of HCC to help understand the MR imaging appearance of HCC.

AB - Hepatocellular carcinoma (HCC) is the 6th most common cancer worldwide. Imaging plays a critical role in HCC screening and diagnosis. Initial screening of patients at risk for HCC is performed with ultrasound. Confirmation of HCC can then be obtained by Computed Tomography (CT) or Magnetic Resonance Imaging (MRI), due to the relatively high specificity of both techniques. This article will focus on reviewing MRI techniques for imaging HCC, felt by many to be the exam of choice for HCC diagnosis. MRI relies heavily upon the use of gadolinium-based contrast agents and while primarily extracellular gadolinium-based contrast agents are used, there is an emerging role of hepatobiliary contrast agents in HCC imaging. The use of other non-contrast enhanced MRI techniques for assessing HCC will also be discussed and these MRI strategies will be reviewed in the context of the pathophysiology of HCC to help understand the MR imaging appearance of HCC.

U2 - 10.3390/diagnostics5030383

DO - 10.3390/diagnostics5030383

M3 - Article

VL - 5

SP - 383

EP - 398

JO - Diagnostics

JF - Diagnostics

SN - 2075-4418

IS - 3

ER -